Sotabase

Career

· Postdoctoral Researcher, UC Berkeley2024–

Publications (115)

The Lymphocyte-to-Monocyte Ratio is a Superior Predictor of Overall Survival in Comparison to Established Biomarkers of Resectable Colorectal Cancer
Annals of Surgery · 2016
278
cited
Dual Somatostatin Receptor/FDG PET/CT Imaging in Metastatic Neuroendocrine Tumours: Proposal for a Novel Grading Scheme with Prognostic Significance
Theranostics · 2017
246
cited
Principles of diagnosis and management of neuroendocrine tumours
Canadian Medical Association Journal · 2017
109
cited
T-SNE-CUDA: GPU-Accelerated T-SNE and its Applications to Modern Data
Symposium on Computer Architecture and High Performance Computing · 2018
101
cited
Diagnosis and management of gastrointestinal neuroendocrine tumors: An evidence-based Canadian consensus.
Cancer Treatment Reviews · 2016
95
cited
Epidermal growth factor receptor (EGFR) inhibitors for metastatic colorectal cancer.
Cochrane Database of Systematic Reviews · 2017
95
cited
Follow-up Recommendations for Completely Resected Gastroenteropancreatic Neuroendocrine Tumors
JAMA Oncology · 2018
81
cited
GPU accelerated t-distributed stochastic neighbor embedding
J. Parallel Distributed Comput. · 2019
76
cited
Recurrence in Resected Gastroenteropancreatic Neuroendocrine Tumors
JAMA Oncology · 2018
59
cited
Prognostic and predictive biomarkers in neuroendocrine tumours.
Critical reviews in oncology/hematology · 2017
53
cited
Clinical and imaging-based prognostic factors in radioembolisation of liver metastases from colorectal cancer: a retrospective exploratory analysis
EJNMMI Research · 2017
46
cited
Escalated-dose somatostatin analogues for antiproliferative effect in GEPNETS: a systematic review
Endocrine · 2017
41
cited
Everolimus in the management of metastatic neuroendocrine tumours
Therapeutic Advances in Gastroenterology · 2017
38
cited
The role of biological therapy in metastatic colorectal cancer after first-line treatment: a meta-analysis of randomised trials
British Journal of Cancer · 2014
35
cited
See, Say, and Segment: Teaching LMMs to Overcome False Premises
Computer Vision and Pattern Recognition · 2023
34
cited
Avelumab in unresectable/metastatic, progressive, grade 2-3 neuroendocrine neoplasms (NENs): Combined results from NET-001 and NET-002 trials.
European Journal of Cancer · 2022
29
cited
High Metabolic Tumour Volume on 18-Fluorodeoxyglucose Positron Emission Tomography Predicts Poor Survival from Neuroendocrine Neoplasms
Neuroendocrinology · 2019
28
cited
Outcomes of Cytoreductive Surgery for Metastatic Low-Grade Neuroendocrine Tumors in the Setting of Extrahepatic Metastases
Annals of Surgical Oncology · 2018
26
cited
Dual PET Imaging in Bronchial Neuroendocrine Neoplasms: The NETPET Score as a Prognostic Biomarker
Journal of Nuclear Medicine · 2021
25
cited
In vivo quantification of 177Lu with planar whole-body and SPECT/CT gamma camera imaging
EJNMMI Physics · 2015
24
cited
Sotabase